Literature DB >> 21509821

Cancellous bone formation response to simulated resistance training during disuse is blunted by concurrent alendronate treatment.

Joshua M Swift1, Sibyl N Swift, Mats I Nilsson, Harry A Hogan, Scott D Bouse, Susan A Bloomfield.   

Abstract

The purpose of this study was to assess the effectiveness of simulated resistance training (SRT) exercise combined with alendronate (ALEN) in mitigating or preventing disuse-associated losses in cancellous bone microarchitecture and formation. Sixty male Sprague-Dawley rats (6 months old) were randomly assigned to either cage control (CC), hind limb unloading (HU), HU plus either ALEN (HU + ALEN), SRT (HU + SRT), or a combination of ALEN and SRT (HU + SRT/ALEN) for 28 days. HU + SRT and HU + SRT/ALEN rats were anesthetized and subjected to muscle contractions once every 3 days during HU (four sets of five repetitions, 1000 ms isometric + 1000 ms eccentric). Additionally, HU + ALEN and HU + SRT/ALEN rats received 10 µg/kg of body weight of ALEN three times per week. HU reduced cancellous bone-formation rate (BFR) by 80%, with no effect of ALEN treatment (-85% versus CC). SRT during HU significantly increased cancellous BFR by 123% versus CC, whereas HU + SRT/ALEN inhibited the anabolic effect of SRT (-70% versus HU + SRT). SRT increased bone volume and trabecular thickness by 19% and 9%, respectively, compared with CC. Additionally, osteoid surface (OS/BS) was significantly greater in HU + SRT rats versus CC (+32%). Adding ALEN to SRT during HU reduced Oc.S/BS (-75%), Ob.S/BS (-72%), OS/BS (-61%), and serum TRACP5b (-36%) versus CC. SRT and ALEN each independently suppressed a nearly twofold increase in adipocyte number evidenced with HU and inhibited increases in osteocyte apoptosis. These results demonstrate the anabolic effect of a low volume of high-intensity muscle contractions during disuse and suggest that both bone resorption and bone formation are suppressed when SRT is combined with bisphosphonate treatment.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509821     DOI: 10.1002/jbmr.407

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Alendronate does not prevent long bone fragility in an inactive rat model.

Authors:  K Naruse; K Uchida; M Suto; K Miyagawa; A Kawata; K Urabe; M Takaso; M Itoman; Y Mikuni-Takagaki
Journal:  J Bone Miner Metab       Date:  2015-10-16       Impact factor: 2.626

Review 2.  Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis.

Authors:  Sarah E Little-Letsinger; Janet Rubin; Brian Diekman; Clinton T Rubin; Cody McGrath; Gabriel M Pagnotti; Eric L Klett; Maya Styner
Journal:  Semin Cell Dev Biol       Date:  2021-09-04       Impact factor: 7.727

3.  Swimming Activity Prevents the Unloading Induced Loss of Bone Mass, Architecture, and Strength in Rats.

Authors:  Maurício J Falcai; Ariane Zamarioli; Graziela Bianchi Leoni; Manoel Damião de Sousa Neto; Jose B Volpon
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

4.  Lower-body positive pressure diminishes surface blood flow reactivity during treadmill walking.

Authors:  Junichi Tajino; Akira Ito; Yusuke Torii; Koji Tsuchimoto; Hirotaka Iijima; Xiangkai Zhang; Momoko Tanima; Shoki Yamaguchi; Hiroshi Ieki; Ryosuke Kakinoki; Hiroshi Kuroki
Journal:  BMC Res Notes       Date:  2019-11-08

5.  Protective Effects of Controlled Mechanical Loading of Bone in C57BL6/J Mice Subject to Disuse.

Authors:  Alex DeLong; Michael A Friedman; Scott M Tucker; Andrew R Krause; Allen Kunselman; Henry J Donahue; Gregory S Lewis
Journal:  JBMR Plus       Date:  2019-12-27

6.  Jump exercise during hindlimb unloading protect against the deterioration of trabecular bone microarchitecture in growing young rats.

Authors:  Yong-In Ju; Teruki Sone; Kazuhiro Ohnaru; Hak-Jin Choi; Kyung-A Choi; Masao Fukunaga
Journal:  Springerplus       Date:  2013-01-31

7.  Beta-1 adrenergic agonist treatment mitigates negative changes in cancellous bone microarchitecture and inhibits osteocyte apoptosis during disuse.

Authors:  Joshua M Swift; Sibyl N Swift; Matthew R Allen; Susan A Bloomfield
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.